C12Y 301/26005
Ribonuclease p
Official title: Ribonuclease P (3.1.26.5)
C12Y301/26005 (Ribonuclease p) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 9
- Assignees
- 7
- Inventors
- 21
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 3 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Multiplex nucleic acid detection system15 Sep 2026US 12,735,754 B2Reditus Laboratories, LLC
- RNA analysis by total hydrolysis and quantification of released nucleosides5 Mar 2024US 11,920,174 B2CureVac AG
- Method for increasing the resistance of a plant to a plant RNA virus22 Sep 2020US 10,781,457 B2Centre National De La Recherche Scientifique
- Method for preparing recombinant proteins through reduction of rnpA gene expression16 Jul 2019US 10,351,890 B2Medicosbiotech, Inc.
- Rna capping efficiency assay18 Jun 2026US 2026/0167661 A1BioNTech SE
- Compositions and methods for the diagnosis of systemic autoimmune disease9 Jan 2025US 2025/0012796 A1Inova Diagnostics, Inc.
- Rapid assembly of multiplex grna arrays24 Oct 2024US 2024/0355419 A1
- Multiplex nucleic acid detection system10 Aug 2023US 2023/0250494 A1Reditus Laboratories, LLC
- Rna analysis by total hydrolysis4 Apr 2019US 2019/0100784 A1CureVac AG
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.